Artesunate in Preemptive Treatment of Human Cytomegalovirus (CMV) in Stem Cell Transplant Recipients
type: MedicalStudy
description: Phase III Study Evaluating the Safety and Efficacy of Artesunate in Preemptive Treatment of Human Cytomegalovirus Disease in Stem Cell Transplant Recipients
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2006-07
end date: 2010-03
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00284687
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Hadassah Medical Organization
study subject: Cytomegalovirus Infections
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Cytomegalovirus Infections

AI Analytics
type: Organization